Related Experiment Videos
Improving cystine stone therapy: an in vitro study of dissolution
D Heimbach1, D Jacobs, S C Müller
1Department of Urology, University of Bonn, Germany.
Urology
|February 2, 2000
Summary
Local chemolysis using tris-(hydroxymethylene)-aminomethane (THAM) and acetylcysteine effectively dissolves cystine stones. This combination therapy shows a significantly higher dissolution rate compared to standard solutions, offering a promising treatment strategy for cystine calculi.
Area of Science:
- Urology
- Nephrology
- Biochemistry
Background:
- Cystine stones are a type of kidney stone caused by a genetic disorder leading to excessive cystine excretion.
- Current treatments for cystine stones include hydration, alkalinization, and surgical removal, which have limitations.
Purpose of the Study:
- To evaluate the efficacy of different chemolysis solutions for dissolving cystine stones in vitro.
- To identify optimal therapeutic strategies for cystine stone treatment.
Main Methods:
- Artificial cystine stones (Bon(n)-Stones) were subjected to chemolysis using various solvents, including artificial urine, saline, acetylcysteine, and tris-(hydroxymethylene)-aminomethane (THAM), and their combinations.
- An experimental setup simulated physiological conditions of the upper urinary tract with computer-assisted online data measurement at varying pH levels.
Main Results:
- All tested solutions demonstrated improved cystine stone solubility compared to artificial urine and saline.
- The combination of THAM at pH 10 and 2% acetylcysteine exhibited the highest dissolution rate (13.91 +/- 1.73 mg/hr).
- This optimal combination showed a 41-fold greater ability to dissolve cystine calculi than artificial urine.
Conclusions:
- Local chemolysis with specifically formulated solutions presents an effective therapeutic approach for managing cystine stones.
- The combination of THAM and acetylcysteine offers a potent in vitro method for dissolving cystine calculi.